|
Volumn 369, Issue 16, 2013, Pages 1561-1563
|
Angiogenesis in glioblastoma
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ANTINEOPLASTIC AGENT;
BEVACIZUMAB;
TEMOZOLOMIDE;
VASCULOTROPIN;
ARTICLE;
BLOOD VESSEL PERMEABILITY;
CANCER CHEMOTHERAPY;
CANCER GROWTH;
CANCER PROGNOSIS;
CANCER RADIOTHERAPY;
CANCER RECURRENCE;
CANCER RESISTANCE;
CANCER STEM CELL;
CANCER SURGERY;
CANCER SURVIVAL;
CELL DIFFERENTIATION;
GLIOBLASTOMA;
HUMAN;
NONHUMAN;
OVERALL SURVIVAL;
PRIORITY JOURNAL;
PROGRESSION FREE SURVIVAL;
SURVIVAL TIME;
TUMOR MICROENVIRONMENT;
TUMOR VASCULARIZATION;
|
EID: 84885706199
PISSN: 00284793
EISSN: 15334406
Source Type: Journal
DOI: 10.1056/NEJMcibr1309402 Document Type: Article |
Times cited : (200)
|
References (5)
|